João Lourinho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
João Lourinho has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Aida Pereira
Serviço de Doenças Infeciosas, Centro Hospitalar Universitário Lisboa Norte (CHULN), EPE, Hospital de Santa Maria, 1649-028 Lisboa, Portugal
2 shared publications - Ana Virgolino
Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal
2 shared publications - Andreia Meseiro
Serviço de Medicina, Centro Hospitalar Barreiro Montijo, EPE, 2830-003 Barreiro, Portugal
2 shared publications - Andreia Ribeiro
Serviço de Medicina, Hospital Vila Franca de Xira, EPE, 2600-009 Vila Franca de Xira, Portugal
2 shared publications - Carolina Ferraz
Lean Health Portugal, 1749-016 Lisboa, Portugal
2 shared publications - Cristina Soeiro
Centro Hospitalar do Baixo Vouga, EPE, 3810-164 Aveiro, Portugal
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2026 (1) , 1322365
Persistent CMV IgM Without IgG Seroconversion in an Immunomodulated Pregnant Woman: A Case Report
Background: Congenital cytomegalovirus (CMV) infection is the most common intrauterine infection worldwide. Maternal primary infection is diagnosed with presence of IgM antibodies, detection of IgG with low avidity index, and/or IgG seroconversion in sequential serum samples. We report the first case of a pregnant woman with persistent CMV IgM positivity without IgG seroconversion, which raises significant questions regarding immune response and fetal risk assessment. Case report: A 39‐year‐old woman, with a history of ankylosing spondylitis and biologic immunosuppression, exhibited persistent CMV IgM positivity and high‐level viremia without IgG seroconversion over two years of fertility support follow‐up. During her pregnancy, CMV IgM remained positive with transient viremia. Fetal evaluations were normal, and CMV DNA was not detected in amniotic fluid. The infant was born healthy, and, to date, no neurodevelopmental changes have been identified. Conclusion: This case underscores a rare immunological profile with significant implications for CMV diagnosis and fetal risk assessment. Persistent CMV IgM without IgG seroconversion, although rare, may occur in patients undergoing immunomodulatory therapies, complicating the interpretation of maternal and fetal risk. This scenario requires individualized care and a multidisciplinary approach.
- 1 January 2026
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2026 (1) , 1322365
Open AccessPersistent CMV IgM Without IgG Seroconversion in an Immunomodulated Pregnant Woman: A Case Report
Background: Congenital cytomegalovirus (CMV) infection is the most common intrauterine infection worldwide. Maternal primary infection is diagnosed with presence of IgM antibodies, detection of IgG with low avidity index, and/or IgG seroconversion in sequential serum samples. We report the first case of a pregnant woman with persistent CMV IgM positivity without IgG seroconversion, which raises significant questions regarding immune response and fetal risk assessment. Case report: A 39‐year‐old woman, with a history of ankylosing spondylitis and biologic immunosuppression, exhibited persistent CMV IgM positivity and high‐level viremia without IgG seroconversion over two years of fertility support follow‐up. During her pregnancy, CMV IgM remained positive with transient viremia. Fetal evaluations were normal, and CMV DNA was not detected in amniotic fluid. The infant was born healthy, and, to date, no neurodevelopmental changes have been identified. Conclusion: This case underscores a rare immunological profile with significant implications for CMV diagnosis and fetal risk assessment. Persistent CMV IgM without IgG seroconversion, although rare, may occur in patients undergoing immunomodulatory therapies, complicating the interpretation of maternal and fetal risk. This scenario requires individualized care and a multidisciplinary approach.
- Open Access
- 25 July 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (15) , 1812
HIV Infection in Portugal: Measuring the Time Between Linkage to Care and Antiretroviral Therapy Initiation
Background/Objectives: The timely initiation of antiretroviral therapy (ART) in persons living with HIV (PLWH) can improve clinical outcomes. However, ART commencement is often delayed. Portugal, despite having one of the highest new HIV diagnosis rates within the European Union, has limited available national-level data. Prior evidence from 2017 to 2018 suggests that the average time to ART initiation exceeds the recommendations for optimal patient benefits. This study aimed to determine the number of days from the first hospital appointment to the commencement of ART among newly diagnosed PLWH in Portugal between 2017 and 2022 at the national level and across different hospitals. It was hypothesized that newly diagnosed PLWH in Portugal experience a delay in ART initiation beyond the recommended timeframe. Methods: A retrospective analysis of records from Portuguese public tertiary care hospitals, which manage most HIV patients, was conducted. Descriptive statistics (measures of central tendency, dispersion, and frequency) were applied, along with association tests and a binary logistic regression model to examine factors influencing the timing of ART initiation. Results: A total of 2229 cases (out of 3434 received) from 19 hospitals were considered eligible. The median time interval between the first hospital appointment and ART initiation was 29.00 days, with a decreasing tendency between 2017 and 2022. Patients initiating therapy after 14 days had higher CD4 levels and lower viral loads compared to those starting within 14 days, with statistical significance. Conclusions: Continuous and regular monitoring of key indicators, such as the time to ART initiation, is pivotal for assessing the effectiveness of HIV treatment programs and pinpointing areas in need of improvement.
- 25 July 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (15) , 1812
Open AccessHIV Infection in Portugal: Measuring the Time Between Linkage to Care and Antiretroviral Therapy Initiation
Background/Objectives: The timely initiation of antiretroviral therapy (ART) in persons living with HIV (PLWH) can improve clinical outcomes. However, ART commencement is often delayed. Portugal, despite having one of the highest new HIV diagnosis rates within the European Union, has limited available national-level data. Prior evidence from 2017 to 2018 suggests that the average time to ART initiation exceeds the recommendations for optimal patient benefits. This study aimed to determine the number of days from the first hospital appointment to the commencement of ART among newly diagnosed PLWH in Portugal between 2017 and 2022 at the national level and across different hospitals. It was hypothesized that newly diagnosed PLWH in Portugal experience a delay in ART initiation beyond the recommended timeframe. Methods: A retrospective analysis of records from Portuguese public tertiary care hospitals, which manage most HIV patients, was conducted. Descriptive statistics (measures of central tendency, dispersion, and frequency) were applied, along with association tests and a binary logistic regression model to examine factors influencing the timing of ART initiation. Results: A total of 2229 cases (out of 3434 received) from 19 hospitals were considered eligible. The median time interval between the first hospital appointment and ART initiation was 29.00 days, with a decreasing tendency between 2017 and 2022. Patients initiating therapy after 14 days had higher CD4 levels and lower viral loads compared to those starting within 14 days, with statistical significance. Conclusions: Continuous and regular monitoring of key indicators, such as the time to ART initiation, is pivotal for assessing the effectiveness of HIV treatment programs and pinpointing areas in need of improvement.
- Open Access
- 11 March 2025
- Published by MDPI AG in Preprints.org
HIV Infection in Portugal: Measuring the Time Between Linkage to Care and Antiretroviral Therapy Initiation
Background/Objectives: The timely initiation of antiretroviral therapy (ART) in persons living with HIV (PLWH) improves clinical outcomes. However, ART commencement is often delayed. Portugal, which has one of the highest new HIV diagnosis rates within the European Union, has limited available data. Evidence from 2017-2018 suggests that the average time to ART initiation exceeds the recommendations for optimal benefits. This study aimed to assess the number of days from the first hospital appointment to the commencement of ART among newly diagnosed PLWH in Portugal between 2017 and 2022 at the national level and across different hospitals within the country. Methods: A retrospective analysis of records from Portuguese public tertiary care hospitals, which manage the majority of HIV patients, was conducted. Descriptive statistics (measures of central tendency, dispersion, and frequency) were applied, along with association tests and a binary logistic regression model to examine factors influencing the timing of ART initiation. Results: A total of 2,229 cases from 19 hospitals were considered eligible. The median time interval between the first hospital appointment and ART initiation was 29.00 days, with a decreasing tendency between 2017 and 2022. Patients initiating therapy after 14 days had higher CD4 levels and lower viral loads compared to those starting within 14 days, with statistical significance. Conclusions: Continuous and regular monitoring of key indicators, such as the time to ART initiation, is pivotal for assessing the effectiveness of HIV treatment programs and pinpointing areas in need of improvement.
- 11 March 2025
- Published by MDPI AG in Preprints.org
Open AccessHIV Infection in Portugal: Measuring the Time Between Linkage to Care and Antiretroviral Therapy Initiation
Background/Objectives: The timely initiation of antiretroviral therapy (ART) in persons living with HIV (PLWH) improves clinical outcomes. However, ART commencement is often delayed. Portugal, which has one of the highest new HIV diagnosis rates within the European Union, has limited available data. Evidence from 2017-2018 suggests that the average time to ART initiation exceeds the recommendations for optimal benefits. This study aimed to assess the number of days from the first hospital appointment to the commencement of ART among newly diagnosed PLWH in Portugal between 2017 and 2022 at the national level and across different hospitals within the country. Methods: A retrospective analysis of records from Portuguese public tertiary care hospitals, which manage the majority of HIV patients, was conducted. Descriptive statistics (measures of central tendency, dispersion, and frequency) were applied, along with association tests and a binary logistic regression model to examine factors influencing the timing of ART initiation. Results: A total of 2,229 cases from 19 hospitals were considered eligible. The median time interval between the first hospital appointment and ART initiation was 29.00 days, with a decreasing tendency between 2017 and 2022. Patients initiating therapy after 14 days had higher CD4 levels and lower viral loads compared to those starting within 14 days, with statistical significance. Conclusions: Continuous and regular monitoring of key indicators, such as the time to ART initiation, is pivotal for assessing the effectiveness of HIV treatment programs and pinpointing areas in need of improvement.
- Open Access
Missed Opportunities for HIV Diagnosis and Their Clinical Repercussions in the Portuguese Population—A Cohort Study
Late human immunodeficiency virus (HIV) diagnosis has been associated with missed opportunities for earlier diagnosis. We conducted a retrospective, longitudinal, single-centre cohort study evaluating these missed opportunities and their clinical repercussions in adults with a new HIV diagnosis or who were drug-naïve, who attended our Infectious Diseases Department between 2018 and 2023. We assessed missed opportunities in the two years prior to diagnosis or after the last negative HIV test. We compared clinical and laboratorial data from individuals with and without missed opportunities. The primary outcome considered was AIDS-defining conditions at diagnosis. Among the 436 included individuals, 27.1% experienced at least one missed opportunity. Those with missed opportunities were more likely to be female (p = 0.007), older at their first consultation (p < 0.001), born in Africa (p < 0.001) and in countries with a high HIV prevalence (p < 0.001), and have heterosexual transmission (p < 0.001). The adjusted analysis showed that missed opportunities were significantly associated with AIDS-defining conditions at diagnosis (OR 3.23, CI 95% [1.62–6.46], p < 0.001). These findings highlight the impact of missed opportunities on HIV severity, underscoring the need for more targeted interventions to reduce them.
Open AccessMissed Opportunities for HIV Diagnosis and Their Clinical Repercussions in the Portuguese Population—A Cohort Study
Late human immunodeficiency virus (HIV) diagnosis has been associated with missed opportunities for earlier diagnosis. We conducted a retrospective, longitudinal, single-centre cohort study evaluating these missed opportunities and their clinical repercussions in adults with a new HIV diagnosis or who were drug-naïve, who attended our Infectious Diseases Department between 2018 and 2023. We assessed missed opportunities in the two years prior to diagnosis or after the last negative HIV test. We compared clinical and laboratorial data from individuals with and without missed opportunities. The primary outcome considered was AIDS-defining conditions at diagnosis. Among the 436 included individuals, 27.1% experienced at least one missed opportunity. Those with missed opportunities were more likely to be female (p = 0.007), older at their first consultation (p < 0.001), born in Africa (p < 0.001) and in countries with a high HIV prevalence (p < 0.001), and have heterosexual transmission (p < 0.001). The adjusted analysis showed that missed opportunities were significantly associated with AIDS-defining conditions at diagnosis (OR 3.23, CI 95% [1.62–6.46], p < 0.001). These findings highlight the impact of missed opportunities on HIV severity, underscoring the need for more targeted interventions to reduce them.
- Open Access
- 21 January 2024
- Published by Springer Nature in Cureus
- Vol. 16 (1) , e52679
Diabetic Ketoacidosis and Hypertriglyceridemia-Induced Acute Pancreatitis Requiring Plasmapheresis: A Case Report of a Rare Presentation of Type 2 Diabetes Mellitus in Adults
The triad of diabetic ketoacidosis, hypertriglyceridemia, and acute pancreatitis is a rare presentation of diabetes mellitus type 2 in adults. We report a case of a 41 -year -old male who presented at the emergency department with a sudden onset of severe abdominal pain. Diagnosis of diabetic ketoacidosis, hypertriglyceridemia, and acute pancreatitis was made. Triglyceride level was 6056 mg/dL and glycated hemoglobin was 12.6%. Vigorous fluid therapy and continuous infusion of insulin were started, but due to maintained symptoms, a single plasmapheresis session was performed, with significant clinical improvement. This case emphasizes the diagnostic challenges of the triad and highlights the potential role of plasmapheresis in rapidly reducing triglyceride levels.
- 21 January 2024
- Published by Springer Nature in Cureus
- Vol. 16 (1) , e52679
Open AccessDiabetic Ketoacidosis and Hypertriglyceridemia-Induced Acute Pancreatitis Requiring Plasmapheresis: A Case Report of a Rare Presentation of Type 2 Diabetes Mellitus in Adults
The triad of diabetic ketoacidosis, hypertriglyceridemia, and acute pancreatitis is a rare presentation of diabetes mellitus type 2 in adults. We report a case of a 41 -year -old male who presented at the emergency department with a sudden onset of severe abdominal pain. Diagnosis of diabetic ketoacidosis, hypertriglyceridemia, and acute pancreatitis was made. Triglyceride level was 6056 mg/dL and glycated hemoglobin was 12.6%. Vigorous fluid therapy and continuous infusion of insulin were started, but due to maintained symptoms, a single plasmapheresis session was performed, with significant clinical improvement. This case emphasizes the diagnostic challenges of the triad and highlights the potential role of plasmapheresis in rapidly reducing triglyceride levels.